Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK)

Historical Holders from Q1 2023 to Q4 2025

Type / Class
Equity / Common Stock, $0.01 par value per share
Symbol
OTLK on Nasdaq
Shares outstanding
46,752,465
Price per share
$1.58
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
4,043,704
Total reported value
$4,285,787
% of total 13F portfolios
0%
Share change
-1,930,932
Value change
-$2,350,885
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
52
Price from insider filings
$1.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GMS Ventures & Investments 50% +21% $45,303,849 +$20,057,142 29,040,929 +79% GMS VENTURES & INVESTMENTS 27 May 2025
SPHERA FUNDS MANAGEMENT LTD. 7.5% +46% $4,011,425 +$1,337,142 2,571,426 +50% Sphera Funds Management Ltd. 10 Apr 2025
Empery Asset Management, LP 5% -32% $2,472,925 -$914,455 2,332,948 -27% Empery Asset Management, LP 30 Sep 2025
GREAT POINT PARTNERS LLC 5% -23% $4,484,400 2,220,000 0% Great Point Partners, LLC 30 Jun 2025
TANG CAPITAL PARTNERS LP 6.4% $2,624,703 1,682,502 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024
TANG CAPITAL MANAGEMENT LLC 3.4% -37% $3,030,000 -$808,000 1,500,000 -21% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
As of 30 Sep 2025, Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) has 52 institutional shareholders filing 13F forms. They hold 4,043,704 shares. of 46,752,465 outstanding shares (8.6%) .

Institutional Holders of Outlook Therapeutics, Inc. - Common Stock, $0.01 par value per share (OTLK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 179 $283 158.1% 1
2025 Q3 4,043,704 $4,285,787 -$2,350,885 106% 52
2025 Q2 5,938,598 $9,501,555 -$1,298,121 160% 63
2025 Q1 7,084,422 $8,644,858 +$2,800,480 122% 61
2024 Q4 4,545,632 $8,587,260 -$17,551,788 189% 60
2024 Q3 7,927,898 $42,334,234 -$3,223,883 534% 65
2024 Q2 8,042,692 $59,354,216 +$2,234,341 738% 63
2024 Q1 7,236,418 $86,189,121 +$86,127,774 1,194% 53
2023 Q3 34,194 $7,557 22.1% 1
2023 Q2 34,194 $59,498 174% 1
2023 Q1 34,194 $37,271 +$37,271 109% 1